The Clinical Cancer Genetics Program coordinates genetic testing and high - risk cancer surveillance for individuals and their families with hereditary cancer syndromes. (mdanderson.org)
Dr. Kasmintan Schrader's research involves the molecular diagnosis and characterization of hereditary cancer syndromes in the research and clinical setting with a view to improved surveillance and treatment of associated cancers (molonc.bccrc.ca)
The U.S. Preventive Services Task Force (USPSTF) recommends against screening for ovarian cancer in women without symptoms and who are not known to be at high risk (such as those who have certain hereditary cancer syndromes that increase the risk for ovarian cancer). (sciencedaily.com)